Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1144286162
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
300 UCLA Medical Plz Ste B200
Los Angeles, CA, 90095
Phone (310) 794-1195
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
663 services
Medicare patients, 2024
301
Average age 66
Drug cost, 2024
$2.4M
1,847 prescriptions
Company payments, 2025
$65K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn S Eliashiv was code 95720 (neurologic), 152 times for 67 patients. In total Dawn S Eliashiv billed 663 services in 25 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 152 | 67 | $171.77 | $26K |
| 95819 Neurologic | Facility | 123 | 119 | $45.49 | $5,595 |
| 99232 Hospital E&M - Subsequent | Facility | 97 | 34 | $65.34 | $6,338 |
| 95718 Neurologic | Facility | 52 | 35 | $110.70 | $5,756 |
| 99215 Office E&M - Established | Office | 51 | 32 | $130.90 | $6,676 |
| 99214 Office E&M - Established | Office | 45 | 38 | $98.16 | $4,417 |
| 99223 Hospital E&M - Initial | Facility | 30 | 29 | $134.59 | $4,038 |
| 95983 Electrical Nerve Conductivity | Office | 17 | 11 | $32.93 | $560 |
By year: 2022 $72K for 633 services; 2023 $77K for 718 services; 2024 $67K for 663 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dawn S Eliashiv prescribed most often to Medicare patients was Lacosamide, with 292 prescriptions and refills. In total Dawn S Eliashiv wrote 1,847 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 292 | 314 | 38 | $24K |
| Xcopri Cenobamate | 227 | 249 | 29 | $308K |
| Briviact Brivaracetam | 175 | 191 | 23 | $381K |
| Lamotrigine Generic | 172 | 304 | 32 | $3,344 |
| Clobazam Generic | 141 | 180 | 24 | $35K |
| Levetiracetam Generic | 138 | 223 | 28 | $6,284 |
| Aptiom Eslicarbazepine Acetate | 85 | 101 | 11 | $264K |
| Fycompa Perampanel | 84 | 92 | 12 | $112K |
| Nayzilam Midazolam | 50 | 50 | 17 | $44K |
| Clonazepam Generic | 44 | 44 | Under 11 | $251 |
| Vimpat Lacosamide | 33 | 41 | Under 11 | $55K |
| Phenobarbital Generic | 26 | 32 | Under 11 | $2,194 |
| Epidiolex Cannabidiol (Cbd) | 25 | 25 | Under 11 | $151K |
| Rufinamide Generic | 24 | 24 | Under 11 | $47K |
| Topiramate Generic | 22 | 32 | Under 11 | $189 |
Brand drugs: 820 claims; generic drugs: 1,001 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn S Eliashiv $65K ($65K in general payments such as food, travel and fees) from 6 companies. The largest payer was Medtronic, Inc. with $30K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.